[go: up one dir, main page]

CL2019003739A1 - Probiotic strains of lactobacillus sp. and pediococcus sp. and its use in the development of a probiotic formulation for the prevention of diarrhea caused by bacterial pathogens that affect dogs and cats. - Google Patents

Probiotic strains of lactobacillus sp. and pediococcus sp. and its use in the development of a probiotic formulation for the prevention of diarrhea caused by bacterial pathogens that affect dogs and cats.

Info

Publication number
CL2019003739A1
CL2019003739A1 CL2019003739A CL2019003739A CL2019003739A1 CL 2019003739 A1 CL2019003739 A1 CL 2019003739A1 CL 2019003739 A CL2019003739 A CL 2019003739A CL 2019003739 A CL2019003739 A CL 2019003739A CL 2019003739 A1 CL2019003739 A1 CL 2019003739A1
Authority
CL
Chile
Prior art keywords
probiotic
pediococcus
lactobacillus
cats
prevention
Prior art date
Application number
CL2019003739A
Other languages
Spanish (es)
Inventor
Roberto Toledo Alonso Jorge
Rayen Quilodrán Vega Sandra
Andrés Sandoval Sandoval Felipe
Esteban Aguirre Calfante Alex
Cecilia Portillo Henriquez Brigida
Javier Ramírez Valenzuela Francisco
Isabel Pino Binimelis Ana
Fabiola Fernández Elgueta Katherina
César Villena Julio
Albarracín Leonardo
Original Assignee
Univ Concepcion
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Concepcion filed Critical Univ Concepcion
Priority to CL2019003739A priority Critical patent/CL2019003739A1/en
Publication of CL2019003739A1 publication Critical patent/CL2019003739A1/en
Priority to PCT/CL2020/050128 priority patent/WO2021119868A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Fodder In General (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Se presenta la cepa probiótica de Lactobacillus sp. RGM 2852 y la cepa probiótica de Pediococcus sp. RGM 2609, y el uso de ambas en la elaboración de una formulación probiótica para la prevención de diarreas causadas por patógenos bacterianos que afectan a perros y gatos. Esta formulación puede presentarse como un polvo granulado liofilizado o en forma de microcápsulas, los que al ser soluble en agua u otros líquidos permite disponer de las cepas probioticas en alimentos para mascotas, ya sean líquidos o jaleas.The probiotic strain of Lactobacillus sp. RGM 2852 and the probiotic strain of Pediococcus sp. RGM 2609, and the use of both in the preparation of a probiotic formulation for the prevention of diarrhea caused by bacterial pathogens that affect dogs and cats. This formulation can be presented as a lyophilized granulated powder or in the form of microcapsules, which, being soluble in water or other liquids, allow the probiotic strains to be used in pet food, whether they are liquids or jellies.

CL2019003739A 2019-12-18 2019-12-18 Probiotic strains of lactobacillus sp. and pediococcus sp. and its use in the development of a probiotic formulation for the prevention of diarrhea caused by bacterial pathogens that affect dogs and cats. CL2019003739A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CL2019003739A CL2019003739A1 (en) 2019-12-18 2019-12-18 Probiotic strains of lactobacillus sp. and pediococcus sp. and its use in the development of a probiotic formulation for the prevention of diarrhea caused by bacterial pathogens that affect dogs and cats.
PCT/CL2020/050128 WO2021119868A1 (en) 2019-12-18 2020-10-13 Probiotic strains of lactobacillus sp. and of pediococcus sp. and use thereof in the preparation of a probiotic formulation for the prevention of diarrhea caused by bacterial pathogens that affect dogs and cats

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2019003739A CL2019003739A1 (en) 2019-12-18 2019-12-18 Probiotic strains of lactobacillus sp. and pediococcus sp. and its use in the development of a probiotic formulation for the prevention of diarrhea caused by bacterial pathogens that affect dogs and cats.

Publications (1)

Publication Number Publication Date
CL2019003739A1 true CL2019003739A1 (en) 2020-06-19

Family

ID=71143869

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2019003739A CL2019003739A1 (en) 2019-12-18 2019-12-18 Probiotic strains of lactobacillus sp. and pediococcus sp. and its use in the development of a probiotic formulation for the prevention of diarrhea caused by bacterial pathogens that affect dogs and cats.

Country Status (2)

Country Link
CL (1) CL2019003739A1 (en)
WO (1) WO2021119868A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117467581B (en) * 2023-12-22 2024-03-08 山东威曼宠物食品有限公司 Pediococcus acidilactici King73 capable of improving canine immunity and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100796963B1 (en) * 2000-05-25 2008-01-22 소시에떼 데 프로듀이 네슬레 소시에떼아노님 New probiotic for pet food
EP1997499A1 (en) * 2007-05-31 2008-12-03 Puleva Biotech, S.A. Mammalian milk microorganisms, compositions containing them and their use for the treatment of mastitis
FI128916B (en) * 2018-02-05 2021-03-15 Vetcare Oy Health beneficial composition and method for the preparation thereof

Also Published As

Publication number Publication date
WO2021119868A1 (en) 2021-06-24

Similar Documents

Publication Publication Date Title
ES2408279B1 (en) PROBIOTIC LACTIC ACID BACTERIA
CO2018013557A2 (en) Compositions comprising bacterial strains
DOP2017000137A (en) BENZAMIDES SUBSTITUTED WITH 1,3-THIAZOL-2-ILO.
CL2012001950A1 (en) Use of a probiotic bacterial strain in the manufacture of a medicament or nutritional composition in humans or animals to alter sleep patterns
CL2019002640A1 (en) Proprietary molecules to reduce virulence of pathogens.
BR112013031325A2 (en) spray-dried lactobacillus strains and cells and their use against helicobacter pylori
CL2014002348A1 (en) Phenicol derived compounds; pharmaceutical composition that includes them; and its use to control or treat bacterial infections in cattle.
MX2022011742A (en) NUTRITIONAL COMPOSITION FOR THE GASTROINTESTINAL ENVIRONMENT TO PROVIDE IMPROVED MICROBIOME AND METABOLIC PROFILE.
CL2013001853A1 (en) Non-negative gram negative bacterium belonging to the betaproteobacteria and subfamily neisseriaceae class; extract that includes it; composition comprising the bacteria or the extract; and its use to treat or prevent dermatological inflammatory disorders.
BR112018014654A2 (en) innovative strain of probiotic bacteria and compositions and uses thereof
RU2015105738A (en) NON-PATHOGENIC STRAIN F18 E. COLI AND ITS APPLICATION
AR101213A1 (en) COMBINATION OF A COMPOUND THAT ATTRACTS HARMFUL ARTHROPODS AND A NATURAL ENEMY
CL2013000994A1 (en) Use of chelating agent and peptide antimicrobial compounds because it serves to inhibit the growth of and / or kill a plant pathogenic microorganism in a plant; composition comprising chelating agent and an antimicrobial agent.
MX387170B (en) In ovo delivery of probiotic cultures
CL2019003739A1 (en) Probiotic strains of lactobacillus sp. and pediococcus sp. and its use in the development of a probiotic formulation for the prevention of diarrhea caused by bacterial pathogens that affect dogs and cats.
CL2020001975A1 (en) Compositions and methods of use of novel strains of lactobacillus fermentum. (divisional request 201801680)
BR112018074107A2 (en) method for reducing egg contamination
WO2014108497A3 (en) Vaccine composition comprising e. coli positive for f18 fimbria and/or f4 fimbria
BR112017027899A2 (en) compositions and methods of use of lamellar bodies for therapeutic purposes
BR112016029890A2 (en) use of hydrothermally treated biomass as a pathogen binder
CL2015001457A1 (en) Symbiotic composition comprising a bifidobacterium probiotic strain and an oligosaccharide component comprising arabino xyl oligosaccharides, useful for inhibiting infection by pathogens in the colon; and food composition that comprises it.
MX2014015450A (en) A SYNERGIC SYMBOLIC COMPOSITION AND ITS USE FOR THE TREATMENT OF INTESTINAL DYSBIOSIS.
MX2018012312A (en) Lactobacillus rhamnosus for use in preparation of fermented products.
CL2016003233A1 (en) Progotic strain rgm 2282 and its use in the prevention of diarrhea caused by bacterial pathogens that affect piglets in the stages of breastfeeding, weaning and post-southeast
BR112016024669A2 (en) synergistic composition comprising a mixture of bacteria of the genus lactobacillus and propionobacterium particularly useful for reducing or eliminating pathogenic contamination in soy flour and its derivatives; methods and their uses.